MedPath

EUSOL BIOTECH CO., LTD.

EUSOL BIOTECH CO., LTD. logo
🇹🇼Taiwan
Ownership
Public
Employees
-
Market Cap
-
Website
http://www.eusol.com.tw

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 3
1 (100.0%)

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Safety and Efficacy of ES135 in Subjects With Spinal Cord Injury

Phase 3
Suspended
Conditions
Spinal Cord Injuries
Interventions
First Posted Date
2017-07-25
Last Posted Date
2024-05-08
Lead Sponsor
Eusol Biotech Co., Ltd.
Target Recruit Count
160
Registration Number
NCT03229031
Locations
🇨🇳

Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan

🇨🇳

Far Eastern Memorial Hospital, New Taipei City, Taiwan

🇨🇳

Taipei Veterans General Hospital, Taipei, Taiwan

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.